Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Exemplary coverage

I’m not sure…

That said, I would not be surprised if payment plans (royalty payment plans) began to distort our ability attribute quarterly revenue updates to recent deals.  The SHM would have been a good opportunity to dig into this area further…

On a very related note, Pohl did state that a larger than usual license would likely require a prompt press release.  I think his example was a $225M deal.

Share
New Message
Please login to post a reply